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Abstract 
Objective: Knowledge of risk factors for variant CJD (vCJD) remains limited, 
but transmission of prion proteins via re-useable medical devices, including 
dental instruments, or enhanced susceptibility following trauma to the oral 
cavity is a concern. This study aimed to identify whether previous dental 
treatment is a risk factor for development of vCJD. 
Design: Case control study 
Methods: Risk factor questionnaires completed by interview with relatives of 
130 vCJD patients and with relatives of 66 community and 53 hospital 
controls were examined by a dental surgeon. Responses regarding dental 
treatments were analysed.  
Results: We did not find a statistically significant excess of risk of vCJD 
associated with dental treatments with the exception of extractions in an 
unmatched analysis of vCJD cases with community controls (p=0.02). 
However, this result may be explained by multiple testing.    
Conclusions: This is the first published study to date to examine potential 
links between vCJD and dental treatment. There was no convincing evidence 
found of an increased risk of variant CJD associated with reported dental 
treatment. However, the power of the study is restricted by the number of 
vCJD cases to date and does not preclude the possibility that some cases 
have resulted from secondary transmission via dental procedures. Due to the 
limitations of the data available, more detailed analyses of dental records are 
required to fully exclude the possibility of transmission via dental treatment. 
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INTRODUCTION 
Variant CJD (vCJD) differs from other forms of CJD in that abnormal prion 
protein and probably infectivity are consistently found outside the central 
nervous system. A risk assessment for vCJD and dentistry estimated that the 
risk of transmission of vCJD from dental instruments was low provided 
decontamination procedures were not significantly less effective than 
previously assumed.1 There is a potential for onward transmission of vCJD via 
re-usable medical devices and difficulties in sterilisation of some dental 
instruments, for example endodontic files2 and matrix bands3, which has led to 
continued concerns about the possibility of secondary transmission of vCJD 
through dental procedures. Furthermore, the results of a National survey of 
decontamination in general dental practice in the UK has demonstrated 
widespread short comings in decontamination practice.4 Although the 
disease-associated form of prion protein has been found using bioassays in 
trigeminal ganglion, pulpal tissue and gingival tissue in a hamster model5, and 
in tongue in a mink model6,7, studies in vCJD8 and sporadic CJD9 using 
immuno-histochemistry techniques have been negative. However, despite 
negative immuno-staining and transmission studies in blood from vCJD 
cases, it has now been found that vCJD infection can be transmitted by blood 
transfusion10,11. It is important to examine the evidence from the natural 
disease for all potential risk factors including those where the presumed risk is 
relatively low. Previous case control studies in sporadic CJD12,13 have not 
identified dental treatment as a risk factor. This paper describes an analysis of 
reported dental treatment undergone by cases of vCJD compared with 
community and hospital controls. 
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MATERIALS AND METHODS 
Variant CJD cases were reported to the National Creutzfeldt Jakob Disease 
Surveillance Unit (NCJDSU), Edinburgh14. Ethical approval was obtained from 
a Multi-Centre Research Ethics Approval Committee. Information on potential 
risk factors, including dental treatment, was obtained for each patient through 
face-to-face interview with relatives using a standardised questionnaire. For 
each case, attempts were made to recruit controls from two different groups- 
community (up to four per case) and hospital controls (one per case). 
Community controls were randomly selected individuals registered with the 
same general medical practice as cases, matched by sex and age +/- 4 years. 
Hospital controls were individuals with non-neurological diagnoses, randomly 
selected from another ward in the same hospital as the case and matched to 
cases by sex and age +/- 4 years.  
 
As for cases, face-to-face interviews using a standardised risk factor 
questionnaire with relatives of controls were carried out. Relatives were asked 
“Since the beginning of 1980 has the subject (case or control) received dental 
treatment other than fillings, for example extractions or root canal work”. A 
description of such treatment with dates was sought.  
A dental practitioner (SL) performed a review of relatives’ responses for cases 
and controls. The dental practitioner categorised the treatments and ordered 
them in terms of risk of prion transmission prior to data analysis. Based on 
current published data the highest risk tissue for transmission of vCJD in the 
oropharynx is the lingual and tonsular lymphoid tissue. However, this is 
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unlikely to be traumatised during routine dental treatment1. Lower risks of 
transmission associated with dental treatment were ranked on the basis of 
degree of invasiveness, tissues contacted and the “cleanability” of the 
instruments used (presence of lumens, connectors etc). Root canal treatment 
was judged as highest risk on the grounds that endodontic instruments are 
difficult to clean and are frequently in direct contact with the neurovascular 
tissues in dental pulp.2 Dental extractions were considered the second highest 
risk, followed by crown and bridge work.  
 
STATISTICAL ANALYSIS 
Logistic regression and conditional logistic regression (Stata Statistical 
Software) was used to examine differences between dental histories of the 
cases and controls for the unmatched and matched analyses respectively. 
The frequency of treatments other than root canal treatment, extractions and 
crowns/bridges was too low for meaningful analysis. The following six putative 
risk factors were, therefore, analysed: (1) root canal treatment (identified a 
priori as the highest risk treatment); (2) extractions (identified a priori as the 
second highest risk treatment); (3) crowns/bridges; (4) root canal treatment or 
extractions; (5) root canal treatment, extractions or crowns/bridges and (6) 
any dental treatment. 
RESULTS 
The case-control study has been in operation since the first case of vCJD was 
identified in 1996 and almost all the families of cases (98%) have agreed to 
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take part in the study. There were 159 vCJD cases reported by 31st of 
December 2005; with 156 vCJD cases recruited to the case control study. 26 
cases were excluded from the study because early in the study information on 
dental treatment was only requested for the previous year. For the 130 cases 
of vCJD in this study, 66 had community control data and 53 had hospital 
control data. 
Table 1 shows the frequency of dental treatments undertaken by vCJD cases 
and hospital and community controls. Frequencies of specific treatments were 
broadly similar between cases and both control groups, except for an excess 
of dental extractions seen in vCJD cases compared to community controls 
(p=0.02). No other comparison was significant at the 5% level.  
Results from the matched analyses of cases and controls are shown in Table 
2. Of 66 cases, 25 were matched with one community control, 10 with two 
controls, 20 with three controls and 11 with four controls. Analysis of hospital 
controls matched to cases was based on 53 cases matched with one hospital 
control. These data do not provide convincing evidence of increased risk 
associated with reported dental treatments categorised a priori according to 
potential risk of vCJD transmission. 
 
DISCUSSION 
Many studies have searched for risk factors for the development of different 
types of CJD, such as diet, exposure to animals, surgical treatment, including 
dentistry, and occupational exposures. A retrospective case control study15 of 
60 definite cases of sporadic CJD, occurring in Japan between 1975 and 
1977 found no association with extractions of maxillary or mandibular teeth. 
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An analysis of 26 sporadic CJD cases and 40 matched controls from the 
United States16 failed to discover a significant odds ratio for endodontic 
surgery, though these workers did note statistically significant odds ratios for 
intraocular pressure testing, injury to or surgery on the head, face or neck and 
trauma to other parts of the body. However, these findings suffer from low 
statistical power and, in the case of the Japanese paper, information was 
requested for extractions only during the five year period prior to onset. This 
paper attempts to identify an association between vCJD and reported dental 
treatment. 
Comparison of the reported dental histories of cases and controls found that , 
extractions were the only dental risk factor that reached statistical significance 
(at the 5% level) in the unmatched analysis with community controls. This 
may be a result of multiple testing especially as there are fewer extractions in 
the cases than in the hospital controls. It is likely that the majority of vCJD 
cases in this cohort were infected through eating BSE contaminated meat 
products. Therefore, it is difficult to detect a small subgroup that may have 
been infected by secondary transmission, as in this study, through dentistry.   
There are a number of limitations to this study, most importantly relying on 
reported data from relatives and the relatively small numbers of cases and 
controls resulting in low power to detect statistical differences. Recruitment of 
controls has been problematic17, although every effort was made to maximise 
this group. Selection of controls was not matched for demographic and socio-
economic factors for dental attendance and this may have resulted in bias. It 
is possible that some of the responses of ‘no known treatment’ reflect poor 
knowledge or recall on the part of the relatives. This would reduce the power 
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of the study to pick up significant differences between groups, but not 
necessarily introduce bias.  
Whilst these preliminary data on a topic of great concern for public health, do 
not provide evidence supporting reported dental work as being a major route 
of transmission of the BSE agent to humans to date, they do not preclude the 
possibility that some vCJD cases have been infected by this route. 
Furthermore, the incubation period following infection by a peripheral route 
may be relatively long and therefore the period of observation to date of 
potential secondary transmission of vCJD may be too short to detect cases. 
A more detailed study of previous treatment based on reviewing actual dental 
records rather than relying on reported treatments is required to gain a wider 
insight into the dental history of both cases and controls. We are currently 
investigating the possibility of examining dental records of vCJD cases and a 
larger group of unmatched controls18.  
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Table 1. Dental Treatment Procedures Reported for Cases and Controls 
 
Treatment No. of cases      
( 130) 
No. of 
community 
controls ( 149) 
No. of hospital 
controls ( 53) 
    
Any dental 
treatment 
64 (49%) 59 (40%) 31 (58%) 
Root canal 
treatment 
8 (6%) 9 (6%) 1 (2%) 
Extractions 51 (39%)  39 (26%) 22 (42%) 
Crowns or bridges 8 (6%) 13 (9%) 6 (11%) 
RCT or extractions 56 (43%) 48 (32%) 23 (43%) 
RCT, extractions,  
crown or bridge 
work 
61 (47%) 57 (38%) 29 (55%) 
Dentures or 
Orthodontics 
7 (5%) 2 (1%) 2 (4%) 
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Table 2. Comparison of Reported Dental Treatment Procedures, 
Categorised by Risk, Between Cases and Controls.  
 Cases 
(n=66) vs 
Community 
Controls 
(n=149) 
 Cases (n=53) 
vs Hospital 
Controls 
(n=53) 
 
Putative risk factor OR 95% CI OR 95% CI 
Any dental treatment 
Root canal treatment (RCT) 
1.5 
1.3 
0.8, 2.6 
0.4, 4.3 
0.6 
3.0 
0.3, 1.3 
0.3, 28.8 
Extractions 
Crowns or bridges 
RCT or extractions 
1.7 
0.4 
1.6 
0.9, 3.2 
0.1, 2.0 
0.9, 3.1 
0.7 
0.7 
0.8 
0.3, 1.6 
0.2, 2.4 
0.4, 1.7 
RCT, extractions, crown or 
bridge work 
1.4 0.8, 2.5 0.7 0.3, 1.4 
 
